Drug · DIN 02408562
INSTANYL
100 MCL SINGLE-DOSE NASAL SPRAY
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since July 11, 2016.
- Drug Identification Number (DIN)
- 02408562
- Company (DIN owner)
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Schedule
- Narcotics (cdsa i)
- Dosage form
- Solution
- Route
- Nasal
- Therapeutic class (ATC)
- Fentanyl N02AB03
- Class
- Human
- Record last updated
- September 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FENTANYL (FENTANYL CITRATE) | 200 MCG | DOSE |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 28, 2013: NOC 14507New Drug Submission (NDS)
Other DINs named INSTANYL
- DIN 02408546 · Cancelled Pre Market
- DIN 02408554 · Cancelled Pre Market